Matt, Chris, and Don discuss a new treatment for lung cancer (immunotherapy), the gang discusses a controversy that occurred when a large clinical trial decided to change its endpoint, and Chris dives into the world of linguistics (again).
Journal club article:
Pembrolizumab lung cancer trial)
